RGEN

Repligen Stock Price

150.00
2.46 (1.67%)
150.00
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Repligen Corp RGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
2.46 1.67% 150.00 07:09:47
Close Price Low Price High Price Open Price Previous Close
147.54
Bid Price Ask Price Spread News
145.66 151.87 6.21 - 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3 113 $ 150.00 $ 16,950 349,910 72.32 - 159.97
Last Trade Time Type Quantity Stock Price Currency
07:35:20 4 $ 151.85 USD

Repligen Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.75B 52.50M 46.46M $ 270.25M $ 27.65M 0.44 253.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -19.69k 4.80%

more financials information »

Repligen News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RGEN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week141.01152.41138.00146.20316,6968.996.38%
1 Month153.63153.91138.00146.17327,168-3.63-2.36%
3 Months125.91159.97120.1232144.81381,36924.0919.13%
6 Months94.08159.9792.00127.84509,49755.9259.44%
1 Year76.56159.9772.32109.85483,94573.4495.92%
3 Years40.05159.9729.5679.28425,940109.95274.53%
5 Years27.81159.9720.0764.98366,138122.19439.37%

Repligen Description

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in the United States.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.